The EQT Foundation, a branch of the investment organization EQT, will fund breakthrough research grants investigating rare diseases…
Lila Levinson, PhD
Lila is a Science Writer at Bionews. She completed her PhD in neuroscience at the University of Washington, where she studied how the natural flexibility of the human brain can be used to promote recovery after injury. Previously, she has written about science for The Dallas Morning News and the University of Washington Computational Neuroscience Center. She enjoys exploring the Pacific Northwest and spending time with her cat, Fibonacci.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lila Levinson, PhD
A 3-year-old girl with aromatic l-amino acid decarboxylase (AADC) deficiency successfully received the gene therapy Kebilidi (eladocagene exuparvovec-tneq)…
A $27 million grant will enable Cincinnati Children’s to continue to serve as the hub of a network of rare…
Note: This story was updated July 22, 2025, to correct Nippon Shinyaku (NS)…
More than 70 additional patient organizations have joined a joint statement from the European Organization for Rare Diseases (EURORDIS)…
Researchers in Germany are creating an artificial intelligence (AI) tool to help physicians diagnose rare diseases, such as aromatic…
OneMedNet, a provider of real-world healthcare imaging data, will expand its capabilities to enable secure collaboration for researchers investigating rare…